Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo‐Controlled, Biomarker‐Enriched Trial in Patients With the SOD2 Ala/Ala Variant
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Prostate
DOI: 10.1002/pros.24903
Authors: A. Mandl, M. L. Zahurak, N. A. Metri, N. D. Shore, S. Mao, R. R. McKay, M. E. Taplin, R. Z. Szmulewitz, B. L. Maughan, Z. R. Reichert, E. R. Kessler, E. I. Heath, R. Dreicer, C. A. Stein, G. L. Milne, K. S. Sfanos, S. E. Ernst, L. A. Mummert, A. Cruz‐Lebrón, S. L. J. Michel, M. A. Kane, M. Hursey, M. A. Worth, W. D. Wagner, J. R. Eshleman, M. Debeljak, L. Xu, H. Cao, D. Dowling, C. H. Marshall, M. C. Markowski, S. R. Denmeade, M. A. Eisenberger, E. S. Antonarakis, M. A. Carducci, C. J. Paller
Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Carolina Urologic Research Center, Allegheny Health Network, University of California San Diego, Dana-Farber Cancer Institute, University of Chicago Medical Center, Huntsman Cancer Institute, University of Michigan, University of Colorado Cancer Center, University of Colorado Anschutz, The Barbara Ann Karmanos Cancer Institute, University of Virginia, City Of Hope National Medical Center, Vanderbilt University Medical Center, University of Maryland, College Park, Wake Forest University Health Sciences, Wake Forest University, Clemson University, Masonic Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410104520